-
Health Technology Assessment for Molecular Diagnostics: Practices, Challenges, and Recommendations from the Medical Devices and Diagnostics Special Interest Group
-
Identifying the Need for Good Practices in Health Technology Assessment: Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA
-
Challenges in Research and Health Technology Assessment of Rare Disease Technologies:
-
A Health Economics Approach to US Value Assessment Frameworks—Summary and Recommendations of the ISPOR Special Task Force Report 7
-
A Health Economics Approach to US Value Assessment Frameworks—Introduction: An ISPOR Special Task Force Report 1
-
Review of Recent US Value Frameworks—A Health Economics Approach: An ISPOR Special Task Force Report 6
-
Approaches to Aggregation and Decision Making—A Health Economics Approach: An ISPOR Special Task Force Report 5
-
Objectives, Budgets, Thresholds, and Opportunity Costs—A Health Economics Approach: An ISPOR Special Task Force Report 4
-
An Overview of Value, Perspective, and Decision Context—A Health Economics Approach: An ISPOR Special Task Force Report 2
-
Defining Elements of Value in Health Care—A Health Economics Approach: An ISPOR Special Task Force Report 3
-
Checklist for Ascertaining Study Cohorts in Oncology Health Services Research Using Secondary Data
-
Challenges in the Development and Reimbursement of Personalized Medicine—Payer and Manufacturer Perspectives and Implications for Health Economics and Outcomes Research
Most Recent
-
Health Technology Assessment for Molecular Diagnostics: Practices, Challenges, and Recommendations from the Medical Devices and Diagnostics Special Interest Group
-
Identifying the Need for Good Practices in Health Technology Assessment: Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA
-
Challenges in Research and Health Technology Assessment of Rare Disease Technologies: